Home›Search›Translational Cancer Research

Translational Cancer Research

AME Publishing Company · Hong Kong · Est. 1905

ISSN2219-6803

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (2 more)+12

Total90

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.524

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.484

Total Worksi

6,656

Total Citationsi

30,634

2yr Mean Citednessi

1.27

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Oncology; Radiology, Nuclear Medicine and Imaging; Cancer Research.

General Information

Country / RegionHong Kong

Primary LanguageEnglish

1st Year Published1905

Annual Volume~ 506 articles / year

StatusActive (last: 2026)

Total Publications6,656

Publisher OrgAME Publishing Company

OA Since2018

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

AME Publishing Company

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2219-6803

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

754

3.5k

2019

829

2020

502

4.6k

2021

433

3.1k

2022

332

1.7k

2023

523

1.6k

2024

663

580

2025

510

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Radiology, Nuclear Medicine and ImagingQ2

OncologyQ3

Cancer ResearchQ4

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Radiology, Nuclear Medicine and ImagingCancer ResearchOncology

Research Topics (OpenAlex)

Ferroptosis and cancer prognosisCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsCancer-related molecular mechanisms researchLung Cancer Research StudiesMicroRNA in disease regulationHepatocellular Carcinoma Treatment and PrognosisLung Cancer Diagnosis and TreatmentCancer Genomics and DiagnosticsRNA modifications and cancer

Frequently asked questions about Translational Cancer Research

Is Translational Cancer Research a predatory journal?

PubScope has no integrity flags on record for Translational Cancer Research: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Translational Cancer Research?

Translational Cancer Research is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.27.

Is Translational Cancer Research indexed in Scopus and Web of Science?

Translational Cancer Research is indexed in Web of Science, Scopus.

What is the aims and scope of Translational Cancer Research?